Publication: Betulinic acid modulates the expression of hspa and activates apoptosis in two cell lines of human colorectal cancer
Issued Date
2021-11-01
Resource Type
ISSN
14203049
Other identifier(s)
2-s2.0-85117570002
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Molecules. Vol.26, No.21 (2021)
Suggested Citation
Laphatrada Yurasakpong, Chanin Nantasenamat, Saksit Nobsathian, Kulathida Chaithirayanon, Somjai Apisawetakan Betulinic acid modulates the expression of hspa and activates apoptosis in two cell lines of human colorectal cancer. Molecules. Vol.26, No.21 (2021). doi:10.3390/molecules26216377 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/75985
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Betulinic acid modulates the expression of hspa and activates apoptosis in two cell lines of human colorectal cancer
Other Contributor(s)
Abstract
Betulinic acid (BA) is a pentacyclic triterpene usually isolated from botanical sources. Numerous studies have reported the inhibitory effect of BA against human colorectal cancer cells (CRC). However, its effect on the expression of the molecular chaperone HSPA is unclear. The aim of this research is to investigate the anti-cancer activities of BA purified from Piper retrofractum and study its effect on the expression of HSPA in colorectal cancer HCT116 and SW480 cells. The viability of both cancer cells was reduced after they were treated with an increasing dosage of BA. Flow cytometry assay revealed that levels of cell apoptosis significantly increased after incubation with BA in both cancer cells. Pro-apoptotic markers including Bax, cleaved-caspase-3 and cleaved-caspase-9 were increased while anti-apoptotic marker Bcl-2 was decreased after BA treatment. Western blot also showed that the expression of HSPA fluctuated upon BA treatment, whereby HSPA was increased at lower BA concentrations while at higher BA concentrations HSPA expression was decreased. Preliminary molecular docking assay showed that BA can bind to the nucleotide binding domain of the HSP70 at its ADP-bound state of the HSP70. Although further research is needed to comprehend the BA-HSPA interaction, our findings indicate that BA can be considered as potential candidate for the development of new treatment for colorectal cancer.